Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus

about

Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus

Item

http://www.wikidata.org/entity/Q35962511

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@ast

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@en

type

Item

label

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@ast

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@en

prefLabel

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@ast

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@en

P1476

Production of prostaglandin E₂ ...... modified vaccinia Ankara virus

@en

P2093

April H Spesock

http://www.w3.org/2001/XMLSchema#string

David J Pickup

http://www.w3.org/2001/XMLSchema#string

Ian T D Petty

http://www.w3.org/2001/XMLSchema#string

Justin J Pollara

http://www.w3.org/2001/XMLSchema#string

Scott M Laster

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication

Cyclooxygenase in biology and disease.

Biological interactions between herpesviruses and cyclooxygenase enzymes

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases

Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies

Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection

P304

146-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2012.03.019

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

428

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22534090

http://www.w3.org/2001/XMLSchema#string

P932

3353002

http://www.w3.org/2001/XMLSchema#string